Global Organ Preservation Solution Market Insights Forecasts to 2033

• The Global Organ Preservation Solution Market Size was Valued at USD 315.59 Million in 2023
• The Market Size is Growing at a CAGR of 6.73%from 2023 to 2033
• The Worldwide Organ Preservation Solution Market Size is Expected to Reach USD 605.14 Million by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

The Global Organ Preservation Solution Market Size is Anticipated to Exceed USD 605.14 Million by 2033, Growing at a CAGR of 6.73% from 2023 to 2033.

 

Market Overview

Organ preservation solution is a specially prepared solution used to protect and preserve organs outside the body. Organ preservation is the delivery line for organ transplantation or other medical purposes. These solutions are critical for preserving the viability and function of organs from their removal from a donor to transplantation into a patient. Modern transplant services have been made feasible by the capability to employ the potent effect of chilling to detain biological degradation in organs separated from their particular physiological environment. Generally, the liver, kidney, and pancreas are effectively preserved for up to two days by flushing the organs with the University of Wisconsin (UW) organ preservation solution and keeping them at hypothermia (0–5 degrees C). The UW solution is strong because it uses a number of cell impermeant agents, such as lactobionic acid, raffinose, and hydroxyethyl starch) that prevents the cells from swelling during cold ischemic storage.

 

Report Coverage

This research report categorizes the market for the global organ preservation solution market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global organ preservation solution market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global organ preservation solution market.

 

Driving Factors

Multiple organ failure is the general cause of death in ICUs, mainly caused by sepsis. The geriatric patients are at higher risk of acute renal failure due to an age-related decrease in the glomerular filtration rate and renal plasma flow. According to evaluation, up to 20% of individuals with sepsis express acute respiratory failure, and 26–50% develop acute renal failure (Society of Critical Care Medicine). Patients with diabetes become more at risk for multiple organ failure as well as both of these illnesses. Elder patients commonly have illnesses like TB and liver cirrhosis, which may require organ transplantation. These factors have driven the growth of the organ preservation solution market.   

 

Restraining Factors

Organ transplantation requires a lot of supplies, such as highly paid doctors and surgeons, immoderate transportation, and high-cost medicines. The fees associated with inpatient care, organ procurement, preservation, post-surgical patient care, and anti-rejection drugs increase the overall cost. Organ transplantation is highly preferred, but governments could develop more low-priced intermediations or provide financial help for expensive surgeries, especially for those with low incomes. This is the major factor that restricts the growth of the organ preservation solution market.

 

Market Segmentation

The global organ preservation solution market share is classified into solution, technique, and organ.

 

• The UW segment is anticipated to hold the largest share of the global organ preservation solution over the predicted time period.

On the basis of the solution, the global organ preservation solution is divided into UW, custodial HTK, Perfadex, and Celsior. Among these, the UW segment is anticipated to hold the largest share of the global organ preservation solution over the predicted time period. The kidney, liver, and pancreas are flushed and stored by using this solution. UW was the first intracellular preservation medium and it is observed as the gold standard for organ preservation. The greater share of this segment can be allocated to the rising adoption of UW solutions because of the presence of metabolically inert substrates like lactobionate and raffinose, which give better transplantation outcomes, reduce histological injury, and boost the physiological function of organs compared to other solutions.

 

• The static cold storage segment is anticipated to hold the largest share of the global organ preservation solution market over the predicted time period.

On the basis of technique, the global organ preservation solution is divided into static cold storage, hypothermic, and normothermic. Among these, the static cold storage segment is anticipated to hold the largest share of the global organ preservation solution market over the predicted time period. It’s long history of successful approaches has confirmed it as a trusted and manifested method in the area of transplantation. This is a proportionally simple and profitable method compared to alternative preservation techniques. The simplicity of the process makes it available to a broad range of healthcare facilities, including those with limited resources. This technique is used for preserving the liver, lungs, kidneys, pancreas, and heart.

 

• The kidney segment is anticipated to hold the largest share of the global organ preservation solution market over the predicted time period.

On the basis of organ, the global organ preservation solution market is divided into kidney, liver, lungs, heart, and others. Among these, the kidney segment is anticipated to hold the largest share of the global organ preservation solution market over the predicted time period. Kidney transplantation is one of the most commonly executed organ transplantation processes around the world. The generality of end-stage renal diseases, frequently caused by conditions like diabetes and hypertension, contributes to a high demand for kidney transplants. Additionally, it is known that kidney transplants generally show a positive long-term survival result for patients. The positive result and improvement in the status of life for kidney transplant recipients contribute to the continued demand for kidney transplants. These factors generally help to grow the industry landscape.

 

Regional Segment Analysis of the Global Organ Preservation Solution Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the greatest share of the global organ preservation solution market over the predicted timeframe.

 

Get more details on this report -

Request Free Sample PDF

 

North America is anticipated to hold the greatest share of the global organ preservation solution market over the predicted timeframe. The greatest share of this region can be credited to factors, including the growing demand for and adoption of organ transplantation and the increasing number of chronic diseases, like end-stage disease. The need for preservation solutions in the region to ensure organ viability in ex-vivo conditions is another important element contributing to North America's leading position in the worldwide market. 

 

Asia Pacific is anticipated to grow at the fastest rate in the global organ preservation solution market over the predicted timeframe. Rising healthcare funding, rising patient awareness, and increased demand for organ transportation processes. Furthermore, a growing geriatric population, increasing cases of kidney and heart failure, and increasing healthcare expenditures are anticipated to boost the expansion of industry in the upcoming years. The constantly growing requirement to meet the demand for organ donation in this region is driving the growth of the organ preservation solution market.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global organ preservation solution market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Essential Pharmaceuticals, LLC
• Waters Medical Systems
• 21^st Century Medicine
• Accord Healthcare
• OrganOx Limited
• BioLife Solutions, Inc.
• Preservation Solutions, Inc.
• Xvivo Perfusion AB
• Transmedics, Inc.
• Claris Lifesciences Limited
• Franz Kohler Chemie GmbH
• Bridge to Life Limited
• Paragonix Technologies
• TX Innovations
• SALF
• Vascular Perfusion Solutions
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

    

• In March 2022, XVIVO launched EU MDR certification for its kidney Assist Transport system. XVIVO trusts that the certification will permit more patients to approach kidneys donated via the transport system.

 

• In July 2021, TransMedics Group, Inc. introduced the FDA 510 (K) clearance for its OCS Lung Solution. TransMedics trusts that they show their commitment to providing first-class organ preservation products to meet patients requirements for clearance.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Organ Preservation Solution Market based on the below-mentioned segments: 

 

Global Organ Preservation Solution Market, By Solution

• UW
• Custodial HTK
• Perfadex
• Celsior

 

Global Organ Preservation Solution Market, By Technique

• Static Cold Storage
• Hypothermic
• Normothermic

 

Global Organ Preservation Solution Market, By Organ

• Kidney
• Liver
• Lungs
• Heart
• Others

 

Global Organ Preservation Solution Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa